BlackRock’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41M Buy
14,240,175
+16,648
+0.1% +$65.6K ﹤0.01% 2634
2025
Q4
$57.9M Buy
14,223,527
+2,997,391
+27% +$13.4M ﹤0.01% 2433
2025
Q3
$39.9M Buy
11,226,136
+367,236
+3% +$1.33M ﹤0.01% 2644
2025
Q2
$29.6M Sell
10,858,900
-600,840
-5% -$1.24M ﹤0.01% 2794
2025
Q1
$19.3M Sell
11,459,740
-473,336
-4% -$1.32M ﹤0.01% 2963
2024
Q4
$19.5M Buy
11,933,076
+115,781
+1% +$345K ﹤0.01% 3069
2024
Q3
$49.2M Buy
11,817,295
+771,847
+7% +$4.05M ﹤0.01% 2481
2024
Q2
$60.3M Buy
11,045,448
+1,999,304
+22% +$15.9M ﹤0.01% 2310
2024
Q1
$90.5M Buy
9,046,144
+576,922
+7% +$4.32M ﹤0.01% 2107
2023
Q4
$34.6M Buy
8,469,222
+475,259
+6% +$1.75M ﹤0.01% 2710
2023
Q3
$30.9M Buy
7,993,963
+109,186
+1% +$587K ﹤0.01% 2685
2023
Q2
$47M Buy
7,884,777
+82,950
+1% +$478K ﹤0.01% 2523
2023
Q1
$25.5M Buy
7,801,827
+16,476
+0.2% +$65.8K ﹤0.01% 2845
2022
Q4
$30.8M Buy
7,785,351
+824,894
+12% +$4.03M ﹤0.01% 2787
2022
Q3
$41.8M Sell
6,960,457
-34,872
-0.5% -$252K ﹤0.01% 2583
2022
Q2
$45M Buy
6,995,329
+524,453
+8% +$3.34M ﹤0.01% 2564
2022
Q1
$53.5M Buy
6,470,876
+500,173
+8% +$4.04M ﹤0.01% 2547
2021
Q4
$92.4M Buy
5,970,703
+872,033
+17% +$16.8M ﹤0.01% 2263
2021
Q3
$115M Buy
5,098,670
+3,283,779
+181% +$68.9M ﹤0.01% 2126
2021
Q2
$35.7M Buy
1,814,891
+35,575
+2% +$806K ﹤0.01% 2925
2021
Q1
$59.6M Buy
+1,779,316
New +$57.9M ﹤0.01% 2512

Other funds holding SANA